Cargando…
The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
The recent expansion of multidrug resistant and pan-drug-resistant pathogens poses significant challenges in the treatment of healthcare associated infections. An important advancement, is a handful of recently launched new antibiotics targeting some of the current most problematic Gram-negative pat...
Autores principales: | Karaiskos, Ilias, Lagou, Styliani, Pontikis, Konstantinos, Rapti, Vasiliki, Poulakou, Garyphallia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581067/ https://www.ncbi.nlm.nih.gov/pubmed/31245348 http://dx.doi.org/10.3389/fpubh.2019.00151 |
Ejemplares similares
-
Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020) -
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
por: Karaiskos, Ilias, et al.
Publicado: (2014) -
1181. Use of the Combination Antibiogram in the Era of MDR Gram-Negative Pathogens
por: Klinker, Kenneth, et al.
Publicado: (2018) -
PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019) -
Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)